Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Framed for research, not as a safety guarantee
ParlevlietETHeijboerACSchroder-van der ElstJPHavekesLMRomijnJAPijlHet al
Glucagon-like peptide-1 receptor agonist semaglutide through the lens of psychiatry: a systematic review of potential benefits and risks
ARB recalls resurface as Teva pulls 6 lots of losartan from market Teva Pharmaceuticals is pulling six bulk lots of its angiotensin II receptor blocker (ARB) losartan from the market after testing revealed dangerously high levels of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), a probable human carcinogen, in the drugs
US$ 26.42
US$ 26.57
US$ 21.06
US$ 20.98
US$ 26.04
US$ 23.77
US$ 24.02
US$ 21.01
US$ 25.14
